Ulta comparable sales in fiscal 2026
Short Answer
The model assigns meaningfully higher odds (20.0% model vs 0.0% market) for Ulta's comparable sales in fiscal 2026 to be above 3.5%, driven by Q1 fiscal 2026 comparable sales of 5.3% and analyst projections for Ulta to exceed its full-year guidance.
1. Executive Verdict
- Ulta comparable sales likely exceed 3.5% given Q1 fiscal 2026 growth of 5.3%.
- Analysts project Ulta will surpass 3.5%, expecting performance significantly above guidance.
Who Wins and Why
| Outcome | Market | Model | Why |
|---|---|---|---|
| Above 3.5% | 0.0% | 20.0% | Ulta's Q1 fiscal 2026 comparable sales of 5.3% surpassed expectations, supported by analyst projections. |
| Above 4.5% | 0.0% | 20.0% | Ulta's Q1 fiscal 2026 comparable sales of 5.3% surpassed expectations, supported by analyst projections. |
| Above 4% | 0.0% | 20.0% | Ulta's Q1 fiscal 2026 comparable sales of 5.3% surpassed expectations, supported by analyst projections. |
| Above 5.5% | 0.0% | 20.0% | Ulta's Q1 fiscal 2026 comparable sales of 5.3% surpassed expectations, supported by analyst projections. |
| Above 5% | 0.0% | 20.0% | Ulta's Q1 fiscal 2026 comparable sales of 5.3% surpassed expectations, supported by analyst projections. |
Current Context
Ulta Beauty's Q1 2026 performance surpassed internal comparable sales guidance. For the first quarter of fiscal 2026, which ended on May 2, 2026, Ulta Beauty reported a 5.3% increase in comparable sales [^][^][^]. Net sales for the quarter grew 11.1% to $3.2 billion. Operating income increased by 11.6% to $448.3 million, yielding a diluted EPS of $7.74 [^][^].
Ulta Beauty projects 2.5% to 3.5% comparable sales growth for fiscal 2026. The company's full-year guidance for fiscal 2026 also includes net sales growth of 6% to 7% [^][^][^]. Additionally, Ulta Beauty raised its full-year 2026 diluted EPS guidance from an initial range of $28.05 to $28.55 to a revised range of $28.36 to $28.80 [^][^]. Financial analysts, including those at UBS, have expressed optimism regarding Ulta's capacity to maintain growth while simultaneously moderating costs and achieving tighter expense control in fiscal 2026 and beyond [^].
2. Market Behavior & Price Dynamics
Historical Price (Probability)
Outcome probability
Date
The price chart for this market is characterized by a single, sharp movement on August 5, 2026. On that day, the implied probability of Ulta's fiscal 2026 comparable sales growth surpassing 3.5% jumped 75 percentage points, from 1.0% to 76.0%. This spike occurred without any corresponding company announcements or news flow cited for that specific date. The most relevant fundamental data point, Ulta's Q1 2026 earnings report showing a 5.3% increase in comparable sales, was released two months prior in June and does not explain the timing of the August price adjustment.
The most critical factor in this analysis is the complete absence of trading volume. With zero contracts traded, the price action does not reflect transactional price discovery or any genuine market conviction. The shift from 1.0% to 76.0% represents a change in quoted prices, not a level established through buying and selling. Because there is no trading history, technical levels of support and resistance have not been formed. The chart does not indicate a shift in broad market sentiment but rather a quoting adjustment by a single participant or an automated market maker.
3. Significant Price Movements
Notable price changes detected in the chart, along with research into what caused each movement.
📈 August 05, 2026: 75.0pp spike
Price increased from 1.0% to 76.0%
Outcome: Above 3.5%
What happened: The provided web research does not indicate any social media activity, company announcements, or traditional news that would explain a 75.0 percentage point spike in the prediction market "Ulta comparable sales in fiscal 2026" above 3.5% on August 5, 2026. Ulta's Q1 FY26 earnings, reported in June, maintained fiscal 2026 comparable sales guidance at 2.5% to 3.5% [^], which is inconsistent with a surge for an "Above 3.5%" outcome. Furthermore, Ulta Beauty's stock (ULTA) did not experience any significant price spike on August 5, 2026, remaining in its normal trading range [^]. Based on the available information, social media was irrelevant, and the prediction market movement appears uncorroborated by external events.
4. Market Data
Contract Snapshot
This market resolves to "Yes" if Ulta's comparable sales in fiscal year 2026 are above the specified percentage for the chosen contract, and "No" if they are at or below that threshold. Trading for this market series ends on March 11 at 4:00 PM EST. The maximum payout date for settled contracts is June 9, 2027, with no other special settlement conditions described.
Available Contracts
Market options and current pricing
| Outcome bucket | Yes (price) | No (price) | Last trade probability |
|---|---|---|---|
| Above 3.5% | $0.84 | $0.24 | 0% |
| Above 4.5% | $0.44 | $0.64 | 0% |
| Above 4% | $0.64 | $0.44 | 0% |
| Above 5.5% | $0.16 | $0.92 | 0% |
| Above 5% | $0.27 | $0.81 | 0% |
| Above 6.5% | $0.07 | $0.99 | 0% |
| Above 6% | $0.10 | $0.98 | 0% |
| Above 7% | $0.06 | $0.99 | 0% |
Market Discussion
Ulta Beauty has maintained its full-year fiscal 2026 guidance for comparable sales growth in the range of 2.5% to 3.5% [^][^]. The company announced a strong 5.3% comparable sales growth in its fiscal 2026 first quarter, exceeding analyst expectations of approximately 4.6% [^][^][^]. However, investor and analyst commentary remains focused on challenges such as the macroeconomic environment and potential consumer "trade-down" behavior, which reportedly led to downward pressure on shares despite the quarterly beat due to a perceived muted full-year outlook [^][^].
5. How does Ulta's official fiscal 2026 guidance (2.5%-3.5%) compare to its historical accuracy over the past five fiscal years?
| Fiscal 2026 Comparable Sales Guidance | 2.5% to 3.5% (as of Q1 2026 earnings report) [^][^][^][^][^] |
|---|---|
| 2024 Actual Comparable Sales | 0.7% (vs. 4-5% guidance) [^][^] |
| 2025 Actual Comparable Sales | 5.4% (vs. 0-1.5% updated guidance) [^][^] |
Ulta's fiscal 2026 comparable sales guidance is 2.5% to 3.5% [^] [^] [^] [^] [^] . This official guidance, established for comparable sales, was upheld as of the Q1 2026 earnings report in June 2026 [^]. This target contrasts with a historical trend of considerable fluctuation in the company's actual comparable sales performance relative to its initial guidance over the past five completed fiscal years, from 2021 to 2025 [^][^][^][^][^][^].
Ulta's historical comparable sales have shown significant deviation from guidance. The company's actual performance has both significantly underperformed and overperformed its initial targets. For example, in fiscal 2024, actual comparable sales reached only 0.7%, falling short of the 4-5% guidance [^][^]. Conversely, in fiscal 2025, Ulta Beauty achieved 5.4% in actual comparable sales, notably exceeding its updated guidance of 0-1.5% [^][^]. This trend of variability continued in other years as well: fiscal 2022 saw actual sales of 15.6%, far surpassing the 3-4% guidance, and fiscal 2023's actual sales of 5.7% were slightly above the 4-5% guidance [^][^].
6. What macroeconomic indicators for Q3 and Q4 2026, such as retail sales reports or the Consumer Confidence Index, could cause Ulta's sales to deviate from its official guidance?
| Ulta Beauty Fiscal 2026 Comparable Sales Guidance | 2.5% to 3.5% [^][^][^][^] |
|---|---|
| U.S. Retail and Food Services Sales (June 2026) | $768.60B [^][^][^][^][^] |
| Consumer Confidence Index (July 2026) | 90.80 [^][^][^][^][^] |
Ulta Beauty's fiscal 2026 comparable sales guidance, set at 2.5% to 3.5%, is vulnerable to macroeconomic shifts, particularly consumer behavior. This guidance is susceptible to factors such as persistent inflation, elevated interest rates, and energy price volatility [^][^][^][^]. For Q3 and Q4 2026, key U.S. discretionary-demand indicators, including retail sales reports and the Consumer Confidence Index (CCI), are particularly relevant, as they significantly influence consumer confidence and spending patterns for non-essential items [^][^][^][^][^][^][^][^][^].
Retail sales are positive, but consumer confidence has softened recently. As of August 6, 2026, macroeconomic data for Q3 2026 is incomplete, and Q4 2026 data is unavailable [^][^][^][^][^]. However, current indications show U.S. retail and food services sales reached $768.60 billion in June 2026, marking a 0.20% month-over-month increase and a 6.70% year-over-year increase. In contrast, consumer confidence has experienced a modest softening, with the CCI decreasing to 90.80 in July 2026 from 92.20 in June [^][^][^][^][^].
Ulta's sales could deviate based on future retail strength and consumer confidence. Should retail sales maintain their current strength, Ulta's comparable sales could potentially exceed guidance due to increased discretionary beauty spending and higher store traffic [^][^][^][^][^]. Conversely, a slowdown in retail sales during late Q3 or Q4 2026 could lead to comparable sales falling short, as consumers reduce nonessential purchases. A sustained decline in consumer confidence might prompt shoppers to delay premium beauty purchases, reduce basket sizes, or opt for less expensive alternatives, thereby putting pressure on comparable sales. The primary risk to Ulta's fiscal 2026 comparable sales missing guidance is a further deterioration in consumer confidence and retail sales momentum through the remainder of Q3 and into Q4 [^][^][^][^][^].
7. How does the performance of the Ulta Beauty at Target partnership in 2026 compare with the Sephora at Kohl's model as a driver for sales growth?
| Ulta Beauty at Target Partnership End | August 2026 [^][^] |
|---|---|
| Ulta at Target Q1 2026 Foot Traffic YoY | -3.6% [^] |
| Ulta Beauty Q1 FY26 Comparable Sales Growth | 5.3% [^][^][^] |
The Ulta Beauty at Target partnership shows declining performance as a sales growth driver. This collaboration is set to conclude in August 2026. Ulta reported that decreasing royalty income from this partnership contributed to its Q1 FY26 results, indicating a reduced role as a sales growth driver [^][^]. In contrast, the Sephora at Kohl's partnership, despite experiencing a surprise sales decline in Q1 2026, has been noted for providing a more resilient traffic floor compared to the Ulta-at-Target model and was previously a significant growth driver for Kohl's [^][^].
Both partnerships faced foot traffic declines in Q1 2026. Foot traffic data for Q1 2026 showed a -3.6% year-over-year decline for Ulta locations inside Target, while Sephora at Kohl's locations experienced a -2.9% decline [^]. The unexpected sales decrease for Sephora at Kohl's in Q1 2026 has raised concerns about the model potentially peaking or being impacted by broader issues within Kohl's stores [^]. Despite these specific partnership challenges, Ulta Beauty reported overall Q1 FY26 comparable sales growth of 5.3% and projects a full-year fiscal 2026 comparable sales growth of 2.5% to 3.5% [^][^][^].
8. What do alternative data sources, such as foot traffic analytics or credit card transaction data, indicate about Ulta's sales momentum heading into Q4 2026?
| Feb 2026 Foot Traffic Increase | 10.3% [^][^] |
|---|---|
| Apr 2026 Foot Traffic Increase | 3.6% [^][^] |
| Q1 2026 Comparable Sales Growth | 5.3% [^] |
Ulta's Q1 2026 performance exceeded expectations, maintaining annual guidance. The company experienced positive foot traffic momentum in early 2026, which contributed to its Q1 2026 comparable sales surpassing initial projections [^][^][^]. Ulta reported a 5.3% increase in comparable sales for Q1 2026 and consequently maintained its full-year comparable sales growth guidance for fiscal 2026 [^].
Foot traffic analytics show consistent positive momentum for Ulta. Year-over-year visits have increased in nine of the past twelve months, indicating sustained customer engagement [^][^]. Notable increases include a 10.3% jump in February 2026, which was partly driven by a Rare Beauty partnership, and a further 3.6% increase in April 2026 [^][^].
Current research lacks alternative data for Q4, but Ulta projects growth. The available research does not indicate what other alternative data sources, such as credit card transaction data, suggest about Ulta's sales momentum heading into Q4 2026 [^]. As of August 6, 2026, Ulta's financial outlook for fiscal 2026 projects net sales growth of 6% to 7% and comparable sales growth of 2.5% to 3.5% [^].
9. What specific factors are cited by financial analysts, like those at UBS, who project Ulta's performance will exceed its own 2.5%-3.5% guidance for fiscal 2026?
| UBS FY2026 Performance Outlook | Exceeds Ulta's guidance [^][^] |
|---|---|
| Ulta FY2026 Comparable Sales Guidance | 2.5% to 3.5% [^][^][^] |
| Space NK Cost Pressure Impact | Diminishing in H2 FY2026 [^][^] |
Specific efficiencies and investments are driving projected superior performance. UBS points to moderating infrastructure investment, improved returns from recent initiatives, and careful management of marketing and capital allocation as key factors [^][^]. Additionally, analysts expect the cost pressures from the Space NK acquisition to lessen in the latter half of fiscal 2026, contributing to slower overall expense growth and stronger financial outcomes [^][^].
10. What Could Change the Odds
Key Catalysts
Ulta Beauty announced a 5.3% increase in comparable sales for the first quarter of fiscal 2026, which ended May 2, 2026 [^] [^] [^] . For fiscal 2026, the company anticipates full-year comparable sales growth between 2.5% and 3.5%, with net sales growth projected at 6% to 7% [^][^][^]. Key financial KPIs for fiscal 2026 include an operating income growth target of 6.5% to 9%, updated from 6% to 9%, and diluted EPS guidance of $28.36 to $28.80, updated from $28.05 to $28.55 [^][^][^].
Key Dates & Catalysts
- Expiration: June 09, 2027
- Closes: June 09, 2027
11. Decision-Flipping Events
- Trigger: Ulta Beauty announced a 5.3% increase in comparable sales for the first quarter of fiscal 2026, which ended May 2, 2026 [^] [^] [^] .
- Trigger: For fiscal 2026, the company anticipates full-year comparable sales growth between 2.5% and 3.5%, with net sales growth projected at 6% to 7% [^] [^] [^] .
- Trigger: Key financial KPIs for fiscal 2026 include an operating income growth target of 6.5% to 9%, updated from 6% to 9%, and diluted EPS guidance of $28.36 to $28.80, updated from $28.05 to $28.55 [^] [^] [^] .
- Trigger: Potential bullish catalysts include continued store expansion, targeting 50-60 net new stores, alongside the Space NK acquisition [^] [^] [^] [^] .
13. Historical Resolutions
No historical resolution data available for this series.
